|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Audentes Therapeutics, Inc. (BOLD) |
|
|
$59.97 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
45,860,000 |
| Market
Cap: |
2.75(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$59.97 - $59.97 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Orbimed Capital Gp Iv Llc |
10% Owner |
– – • |
2018-03-09 |
4 |
S |
$34.67 |
$2,850,010 |
I/I |
(80,000) |
3,558,000 |
|
- |
|
| Orbimed Capital Gp Iv Llc |
10% Owner |
– – • |
2018-03-08 |
4 |
S |
$34.06 |
$1,990,058 |
I/I |
(58,428) |
3,638,000 |
|
- |
|
| Orbimed Capital Gp Iv Llc |
10% Owner |
– – • |
2018-03-06 |
4 |
S |
$33.03 |
$375,617 |
I/I |
(11,372) |
3,696,428 |
|
- |
|
| Orbimed Capital Gp Iv Llc |
10% Owner |
– – • |
2018-03-05 |
4 |
S |
$36.06 |
$7,212 |
I/I |
(200) |
3,707,800 |
|
- |
|
| Orbimed Capital Gp Iv Llc |
10% Owner |
– – • |
2018-03-02 |
4 |
S |
$35.06 |
$14,827,787 |
I/I |
(421,638) |
3,708,000 |
|
- |
|
| Mosbrooker Eric |
SVP, Chief Commercial Officer |
• – – |
2018-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
31,500 |
31,800 |
|
- |
|
| Lange Louis G |
Director |
– • – |
2017-12-22 |
4 |
AS |
$30.86 |
$92,633 |
I/I |
(3,000) |
4,558 |
|
- |
|
| Lange Louis G |
Director |
– • – |
2017-12-22 |
4 |
AS |
$30.88 |
$463,160 |
D/D |
(15,000) |
425,799 |
|
- |
|
| Prasad Suyash |
Senior VP & Chief Med Officer |
• – – |
2017-12-01 |
4 |
AS |
$28.45 |
$228,264 |
D/D |
(8,000) |
0 |
|
- |
|
| Prasad Suyash |
Senior VP & Chief Med Officer |
• – – |
2017-12-01 |
4 |
OE |
$0.79 |
$6,320 |
D/D |
8,000 |
1,230 |
|
- |
|
| Newman Mary |
SVP, Regulatory Affairs |
• – – |
2017-11-16 |
4 |
AS |
$26.49 |
$268,375 |
D/D |
(10,000) |
0 |
|
- |
|
| Newman Mary |
SVP, Regulatory Affairs |
• – – |
2017-11-16 |
4 |
OE |
$2.19 |
$21,900 |
D/D |
10,000 |
4,260 |
|
- |
|
| Patterson Matthew R |
President & CEO |
• • – |
2017-10-02 |
4 |
AS |
$27.92 |
$418,853 |
I/I |
(15,000) |
171,814 |
|
- |
|
| Patterson Matthew R |
President & CEO |
• • – |
2017-10-02 |
4 |
AS |
$27.92 |
$279,217 |
D/D |
(10,000) |
0 |
|
- |
|
| Patterson Matthew R |
President & CEO |
• • – |
2017-10-02 |
4 |
OE |
$0.78 |
$7,800 |
D/D |
10,000 |
10,000 |
|
- |
|
| Isaly Samuel D |
10% Owner |
– – • |
2017-09-29 |
4 |
S |
$28.25 |
$18,984,000 |
I/I |
(672,000) |
4,129,638 |
|
- |
|
| Lange Louis G |
Director |
– • – |
2017-09-29 |
4 |
S |
$28.12 |
$169,588 |
I/I |
(6,000) |
5,558 |
|
- |
|
| Lange Louis G |
Director |
– • – |
2017-09-29 |
4 |
S |
$28.31 |
$142,315 |
D/D |
(5,000) |
440,799 |
|
- |
|
| Nagler David |
SVP, HR & Corp. Affairs |
• – – |
2017-09-27 |
4 |
AS |
$30.00 |
$112,500 |
D/D |
(3,750) |
0 |
|
- |
|
| Nagler David |
SVP, HR & Corp. Affairs |
• – – |
2017-09-27 |
4 |
OE |
$2.19 |
$8,195 |
D/D |
3,750 |
3,750 |
|
- |
|
| Lange Louis G |
Director |
– • – |
2017-09-25 |
4 |
AS |
$27.99 |
$85,055 |
I/I |
(3,000) |
7,558 |
|
- |
|
| Lange Louis G |
Director |
– • – |
2017-09-25 |
4 |
AS |
$27.85 |
$424,672 |
D/D |
(15,000) |
445,799 |
|
- |
|
| Patterson Matthew R |
President & CEO |
• • – |
2017-09-18 |
4 |
AS |
$25.07 |
$212,010 |
D/D |
(8,458) |
0 |
|
- |
|
| Patterson Matthew R |
President & CEO |
• • – |
2017-09-18 |
4 |
OE |
$0.78 |
$6,597 |
D/D |
8,458 |
8,458 |
|
- |
|
| Patterson Matthew R |
President & CEO |
• • – |
2017-09-15 |
4 |
AS |
$25.00 |
$38,551 |
D/D |
(1,542) |
0 |
|
- |
|
162 Records found
|
|
Page 5 of 7 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
